Seqens Seqens

X

Find Migalastat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Migalastat
Also known as: Migalastat hcl, 75172-81-5, Deoxygalactonojirimycin hydrochloride, Galafold, 1-deoxygalactonojirimycin hydrochloride, Amigal
Molecular Formula
C6H14ClNO4
Molecular Weight
199.63  g/mol
InChI Key
ZJIHMALTJRDNQI-OLALXQGDSA-N
FDA UNII
CLY7M0XD20

1 2D Structure

Migalastat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride
2.1.2 InChI
InChI=1S/C6H13NO4.ClH/c8-2-3-5(10)6(11)4(9)1-7-3;/h3-11H,1-2H2;1H/t3-,4+,5+,6-;/m1./s1
2.1.3 InChI Key
ZJIHMALTJRDNQI-OLALXQGDSA-N
2.1.4 Canonical SMILES
C1C(C(C(C(N1)CO)O)O)O.Cl
2.1.5 Isomeric SMILES
C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O.Cl
2.2 Other Identifiers
2.2.1 UNII
CLY7M0XD20
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-butyl-2-(hydroxylmethyl)piperidine-3,4,5-triol

2. 1-deoxy-galactonojirimycin

3. 1-deoxygalacto-nojirimycin

4. 1-deoxygalactonojirimycin

5. At1001 Deoxyjirimycin

6. Galafold

7. Gr181413a

8. Lucerastat

9. Migalastat

10. Migalastat Hcl

11. N-butyldeoxygalacto-nojirimycin

12. N-butyldeoxygalactonojirimycin

13. Nb-dgj

2.3.2 Depositor-Supplied Synonyms

1. Migalastat Hcl

2. 75172-81-5

3. Deoxygalactonojirimycin Hydrochloride

4. Galafold

5. 1-deoxygalactonojirimycin Hydrochloride

6. Amigal

7. Migalastat Hydrochloride [usan]

8. Migalastat (hydrochloride)

9. Cly7m0xd20

10. 75172-81-5 (hcl)

11. At-1001 (migalastat Hydrochloride)

12. (2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol Hydrochloride

13. (2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol Hydrochloride.

14. Gr181413a

15. Unii-cly7m0xd20

16. Migalastathcl

17. Galafold (tn)

18. Deoxygalactonojirimycin,hydrochloride

19. Deoxygalactonojirimycin, Hydrochloride

20. 1-deoxygalactonojirimycin Hcl

21. Schembl3802618

22. Chembl2107355

23. Dtxsid801026249

24. (+)-migalastat Hydrochloride

25. Hy-14929a

26. Mfcd00269962

27. Migalastat Hydrochloride (jan/usan)

28. Migalastat Hydrochloride [mi]

29. Migalastat Hydrochloride [jan]

30. 3,4,5-piperidinetriol, 2-(hydroxymethyl)-, Hydrochloride, (2r,3s,4r,5s)-

31. At13690

32. Cs-6380

33. Migalastat Hydrochloride [who-dd]

34. Migalastat Hydrochloride [orange Book]

35. D05031

36. 1,5-dideoxy-1,5-imino-d-galactitol Hydrochloride

37. W-203722

38. Q27275527

39. (+)-(2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol Hydrochloride

40. (2r,3s,4r,5s)-2-(hydroxymethyl)-3,4,5-piperidinetriol Hydrochloride

41. (2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride

42. 3,4,5-piperidinetriol, 2-(hydroxymethyl)-, Hydrochloride (1:1), (2r,3s,4r,5s)-

43. 3,4,5-piperidinetriol, 2-(hydroxymethyl)-, Hydrochloride,[2r-(2a,3a,4a,5b)]-

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 199.63 g/mol
Molecular Formula C6H14ClNO4
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count5
Rotatable Bond Count1
Exact Mass199.0611356 g/mol
Monoisotopic Mass199.0611356 g/mol
Topological Polar Surface Area93 Ų
Heavy Atom Count12
Formal Charge0
Complexity132
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Galafold is indicated for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of Fabry disease (-galactosidase A deficiency) and who have an amenable mutation.


5 Pharmacology and Biochemistry
5.1 ATC Code

A16AX


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY